Publications by authors named "Adrian B Tigu"

Claim this Profile
T
Targeting inflammation and oxidative stress in experimental colitis through IL-6 siRNA and ascorbic acid co-loaded trimethyl chitosan nanoparticles.
Dana Hales, Alina Porfire, Diana Cenariu, Adrian Bogdan Ţigu, Mădălina Nistor

Int J Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-depth analysis for TKI-driven real-world management of 201 CML patients using TFR.
Mihnea Lucian Micu, Simion Florin Cira, Mihnea Zdrenghea, Anca Bojan, Andrada Parvu, Adrian Bogdan Tigu

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive cellular therapies in non-Hodgkin lymphomas.
David Kegyes, Bogdan Borlea, Marc Damian, Adrian Bogdan Tigu, Madalina Nistor

Best Pract Res Clin Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive cellular therapies in multiple myeloma.
David Kegyes, Bogdan Borlea, Marc Damian, Adrian Bogdan Tigu, Madalina Nistor

Best Pract Res Clin Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies.
David Kegyes, Andrei Tat, Alin Stefan Vizitiu, Daiana Vazar-Tripon, Radu Ilie, Adrian Bogdan Tigu

Cell Death Discov· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.
David Kegyes, Anamaria Bancos, Adrian Bogdan Tigu, Ioana Rus, Delia Dima

Biomark Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the preclinical design and assessment of CAR-T cells.
Radu Tomai, Javier De Las Rivas, Bogdan Fetica, Rui Bergantim, Brankica Filipic, Adrian Bogdan Tigu

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Therapies in Melanoma-Targeting DNA Methylation and Histone Modification.
Adrian Bogdan Tigu, Andrei Ivancuta, Andrada Uhl, Alexandru Cristian Sabo, Madalina Nistor

Biomedicines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SERS-Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia.
Anamaria Bancos, Stefania D Iancu, Vlad Moisoiu, Alexandra Ghiaur, Adrian Bogdan Tigu

J Cell Mol Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single low-dose decitabine as frontline therapy of acute myeloid leukaemia, with venetoclax salvage.
Ciprian Jitaru, Mareike Cathrina Peters, Lovisha Aggarwal, Anamaria Bancos, Adrian Bogdan Tigu

J Cell Mol Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miR-18a and miR-532 Levels in Extrahepatic Cholangiocarcinoma.
Rares Ilie Orzan, Adrian Bogdan Țigu, Vlad-Ionuț Nechita, Madalina Nistor, Renata Agoston

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity.
Raluca Andrada Munteanu, Cristian Silviu Moldovan, Adrian Bogdan Tigu, Rares Drula, Richard Feder

Med Pharm Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromes.
Diana Gulei, Vlad Moisoiu, David Kegyes, Rares Drula, Sabina Iluta, Adrian Bogdan Tigu

J Cell Mol Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy.
Radu Andrei Tomai, Sabina Iluta, Adrian Bogdan Tigu, Madalina Nistor, Anamaria Bancos

Diagnostics (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Molecular targets in oncological and hematological disease management: innovations in precision medicine.
Adrian Bogdan Tigu, Gregory Wiedman, Stefan Eugen Szedlacsek

Front Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Modern Bone Markers in Multiple Myeloma: Prospective Analyses Pre and Post-First Line Treatment.
Vlad Stefan Pop, Mihaela Iancu, Adrian Bogdan Țigu, Anda Adam, Gheorghe Tomoaia

Curr Issues Mol Biol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Periodontal Conditions, Salivary Markers, and Systemic Inflammation in Patients with Cardiovascular Diseases.
Carmen Silvia Caloian, Petra Șurlin, Andreea Ciurea, Dana Pop, Bogdan Caloian

Biomedicines· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Novel Frontiers in Cancer Therapy.
Adrian Bogdan Tigu, Ciprian Tomuleasa

Biomedicines· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
imaging system (IVIS) therapeutic assessment of tyrosine kinase inhibitor-loaded gold nanocarriers for acute myeloid leukemia: a pilot study.
Raluca-Andrada Munteanu, Adrian Bogdan Tigu, Richard Feder, Andra-Sorina Tatar, Diana Gulei

Front Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease.
Mihaela I Dregoesc, Adrian B Țigu, Siroon Bekkering, Charlotte D C C van der Heijden, Laura Rodwell

Int J Cardiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effect of the duration of exposure on the carcinogenicity of cadmium in MCF10A mammary epithelial cells.
Alina-Andreea Zimta, Diana Cenariu, Adrian Bogdan Tigu, Cristian Moldovan, Ancuta Jurj

Food Chem Toxicol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis is associated with cardiovascular events in patients with stable coronary artery disease.
Mihaela I Dregoesc, Helin Tercan, Adrian B Țigu, Siroon Bekkering, Leo Ab Joosten

iScience· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The carcinogenic capacity of arsenic in normal epithelial breast cells and double-positive breast cancer cells.
Alina-Andreea Zimta, Diana Cenariu, Adrian Bogdan Tigu, Cristian Moldovan, Ancuta Jurj

Med Pharm Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Relationship between Periodontitis and Systemic Sclerosis Based on the New Periodontitis Classification (2018): A Cross-Sectional Study.
Andreea Ciurea, Alina Stanomir, Petra Șurlin, Iulia Cristina Micu, Cristina Pamfil

Diagnostics (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Mir-205 a possible biomarker for evaluating treatment response in psoriasis?
Carina Mihu, Codruța Alina Popescu, Diana Cenariu, Ştefan Vesa, Adrian Baican, Adrian Bogdan Tigu

J Med Life· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis